Citations (185)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Merve Demirbugen Oz, Fezile Ozdemir, Kenan Can Tok, Emrah Dural, Yagmur Kir, Muge Ulusoy, Mehmet Gumustas, Bora Baskak & H. Sinan Suzen. (2023) The Potential Role of POR*28 and CYP1A2*F Genetic Variations and Lifestyle Factors on Clozapine and N-DesmethylClozapine Plasma Levels in Schizophrenia Patients. Expert Opinion on Drug Metabolism & Toxicology 19:5, pages 319-327.
Read now
Read now
Natasa Djordjevic, Branimir Radmanovic, Jelena Cukic, Dejan Baskic, Slavica Djukic-Dejanovic, Dragan Milovanovic & Eleni Aklillu. (2020) Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism. The World Journal of Biological Psychiatry 21:1, pages 29-52.
Read now
Read now
Zhiyan Liu, Qian Xiang, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Shuqing Chen, Kun Hu, Yanjun Gong, Jie Jiang & Yimin Cui. (2020) The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis. Platelets 31:1, pages 3-14.
Read now
Read now
Varsha Dhamankar, Mahfoud Assem & Maureen D. Donovan. (2015) Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa. Inhalation Toxicology 27:14, pages 767-777.
Read now
Read now
Jolantha Beyerle, Eva Frei, Marie Stiborova, Nina Habermann & Cornelia M. Ulrich. (2015) Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer. Drug Metabolism Reviews 47:2, pages 199-221.
Read now
Read now
José A G Agúndez, Elena García-Martín, Hortensia Alonso-Navarro & Félix Javier Jiménez-Jiménez. (2013) Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert Opinion on Drug Metabolism & Toxicology 9:7, pages 859-874.
Read now
Read now
Marilyn N. Martinez, Leposava Antonovic, Michael Court, Mauro Dacasto, Johanna Fink-Gremmels, Butch Kukanich, Chuck Locuson, Katrina Mealey, Michael J. Myers & Lauren Trepanier. (2013) Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metabolism Reviews 45:2, pages 218-230.
Read now
Read now
Murielle Bochud & Idris Guessous. (2012) Gene–environment interactions of selected pharmacogenes in arterial hypertension. Expert Review of Clinical Pharmacology 5:6, pages 677-686.
Read now
Read now
Miroslav Pohanka. (2012) Acetylcholinesterase inhibitors: a patent review (2008 – present). Expert Opinion on Therapeutic Patents 22:8, pages 871-886.
Read now
Read now
Dong Dong, Baojian Wu, Diana Chow & Ming Hu. (2012) Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling. Drug Metabolism Reviews 44:2, pages 192-208.
Read now
Read now
Li-Ping Yang, Zhi-Wei Zhou, Xiao-Wu Chen, Chun Guang Li, Kevin B. Sneed, Jun Liang & Shu-Feng Zhou. (2012) Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2. Xenobiotica 42:3, pages 238-255.
Read now
Read now
Dong Dong & Baojian Wu. (2012) Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling. Drug Metabolism Reviews 44:1, pages 1-17.
Read now
Read now
J. Sridhar, M. Foroozesh & C.L.
Klein Stevens. (2011) QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR. SAR and QSAR in Environmental Research 22:7-8, pages 681-697.
Read now
Read now
Patrick du Souich & Caroline Fradette. (2011) The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression. Expert Opinion on Drug Metabolism & Toxicology 7:9, pages 1083-1100.
Read now
Read now
Hakan Balibey, Cengiz Basoglu, Stefan Lundgren, Melih O. Babaoglu, Umit Yasar, Hasan Herken, Anders Rane, Atilla Bozkurt & Mesut Cetin. (2011) CYP1A2*1F Polymorphism Decreases Clinical Response to Clozapine in Patients with Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 21:2, pages 93-99.
Read now
Read now
Articles from other publishers (170)
Ziru Dai, Yue Wu, Yuan Xiong, Jingjing Wu, Min Wang, Xiao Sun, Xinxin Ding, Ling Yang, Xiaobo Sun & Guangbo Ge. (2023) CYP1A inhibitors: Recent progress, current challenges, and future perspectives. Medicinal Research Reviews 44:1, pages 169-234.
Crossref
Crossref
Ferenc Fekete, Ádám Menus, Katalin Tóth, Ádám Ferenc Kiss, Annamária Minus, Dávid Sirok, Aleš Belič, Ádám Póti, Gábor Csukly & Katalin Monostory. (2023) CYP1A2 expression rather than genotype is associated with olanzapine concentration in psychiatric patients. Scientific Reports 13:1.
Crossref
Crossref
Shiyao Gu, Qingyong Luo, Cen Wen, Yu Zhang, Li Liu, Liu Liu, Su Liu, Chunhua Chen, Qian Lei & Si Zeng. (2023) Application of Advanced Technologies—Nanotechnology, Genomics Technology, and 3D Printing Technology—In Precision Anesthesia: A Comprehensive Narrative Review. Pharmaceutics 15:9, pages 2289.
Crossref
Crossref
Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani & Ayman O.S. El-Kadi. (2023) Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line. Environmental Toxicology and Pharmacology 101, pages 104214.
Crossref
Crossref
Matthias Henn, Nancy Babio, Dora Romaguera, Zenaida Vázquez-Ruiz, Jadwiga Konieczna, Jesús Vioque, Laura Torres-Collado, Cristina Razquin, Pilar Buil-Cosiales, Montserrat Fitó, Helmut Schröder, Frank B. Hu, Itziar Abete, M. Ángeles Zulet, Tania Fernández-Villa, Vicente Martín, Ramón Estruch, Josep Vidal, Indira Paz-Graniel, J. Alfredo Martínez, Jordi Salas-Salvadó, Miguel A. Martínez-González & Miguel Ruiz-Canela. (2023) Increase from low to moderate, but not high, caffeinated coffee consumption is associated with favorable changes in body fat. Clinical Nutrition 42:4, pages 477-485.
Crossref
Crossref
Himani Sharma, Baddipadige Raju, Gera Narendra, Manoj Kumar, Himanshu Verma, Bhavna Sharma, Gurleen Kaur Tung, Subheet Kumar Jain, Natércia F. Brás & Om Silakari. (2023) In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study. Journal of Molecular Graphics and Modelling 119, pages 108390.
Crossref
Crossref
Samiksha Kukal, Sarita Thakran, Neha Kanojia, Saroj Yadav, Manish Kumar Mishra, Debleena Guin, Pooja Singh & Ritushree Kukreti. (2023) Genic-intergenic polymorphisms of CYP1A genes and their clinical impact. Gene 857, pages 147171.
Crossref
Crossref
Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani & Ayman O.S. El-Kadi. (2023) Modulation of cytochrome P450 1A (CYP1A) enzymes by monomethylmonothioarsonic acid (MMMTAV) in vivo and in vitro. Chemico-Biological Interactions, pages 110447.
Crossref
Crossref
Jian Lu, Xuyang Shang, Bingyi Yao, Dongyi Sun, Jie Liu, Yuanjin Zhang, He Wang, Jingru Shi, Huaqing Chen, Tieliu Shi, Mingyao Liu & Xin Wang. (2023) The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia. Acta Pharmaceutica Sinica B 13:2, pages 648-661.
Crossref
Crossref
Marta Vilčková, Mária Škereňová, Dušan Dobrota, Peter Kaplán, Jana Jurečeková, Ján Kliment, Márk Híveš, Róbert Dušenka, Daniel Evin, Martina Brožová & Monika Sivoňová. (2023) Polymorphisms in the gene encoding CYP1A2 influence prostate cancer risk and progression. Oncology Letters 25:2.
Crossref
Crossref
M. V. Miroshnikov, K. T. Sultanova, M. N. Makarova & V. G. Makarov. (2022) A comparative review of the activity of enzymes of the cytochrome P450 system in humans and laboratory animals. Prognostic value of preclinical models in vivo. Translational Medicine 9:5, pages 44-77.
Crossref
Crossref
Yiting He, Haobin Cen, Lianxia Guo, Tianpeng Zhang, Yi Yang, Dong Dong & Baojian Wu. (2022) Circadian oscillator NPAS2 regulates diurnal expression and activity of CYP1A2 in mouse liver. Biochemical Pharmacology 206, pages 115345.
Crossref
Crossref
Awoniyi O. Awonuga, Charalampos Chatzicharalampous, Mili Thakur, Anupama Rambhatla, Farnoosh Qadri, Modupe Awonuga, Ghassan Saed & Michael P. Diamond. (2021) Genetic and Epidemiological Similarities, and Differences Between Postoperative Intraperitoneal Adhesion Development and Other Benign Fibro-proliferative Disorders. Reproductive Sciences 29:11, pages 3055-3077.
Crossref
Crossref
Mahmoud A. El-Ghiaty, Mohammed A. Alqahtani & Ayman O.S. El-Kadi. (2022) Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1. Chemico-Biological Interactions 364, pages 110049.
Crossref
Crossref
Rozalia-Maria Anastasiadi, Federico Traldi & Marina Resmini. (2022) Imidazole-Based Monomer as Functional Unit for the Specific Detection of Paraxanthine in Aqueous Environments. Chemosensors 10:8, pages 301.
Crossref
Crossref
Shipra Bhatt, Sumit Dhiman, Vinay Kumar, Abhishek Gour, Diksha Manhas, Kuhu Sharma, Probir Kumar Ojha & Utpal Nandi. (2022)
Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using
In Silico
,
In Vitro
, and
In Vivo
Approaches
. ACS Omega 7:23, pages 20321-20331.
Crossref
Crossref
Gaëlle Magliocco, Jules Desmeules, Caroline Flora Samer, Aurélien Thomas & Youssef Daali. (2022)
Evaluation of
CYP1A2
activity: Relationship between the endogenous urinary 6‐hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots
. Clinical and Translational Science 15:6, pages 1482-1491.
Crossref
Crossref
Himanshu Singh, Rajnish Kumar, Avijit Mazumder, Salahuddin, Rupa Mazumder & Mohd. Mustaqeem Abdullah. (2022) Insights into Interactions of Human Cytochrome P450 17A1: A Review. Current Drug Metabolism 23:3, pages 172-187.
Crossref
Crossref
Ferenc Fekete, Katalin Mangó, Annamária Minus, Katalin Tóth & Katalin Monostory. (2022) CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity. Pharmaceutics 14:3, pages 532.
Crossref
Crossref
Marco E. Franco, Karla Johanning, Cole W. Matson & Ramon Lavado. (2022) Reduced biotransformation of polycyclic aromatic hydrocarbons (PAHs) in pollution-adapted Gulf killifish (Fundulus grandis). Science of The Total Environment 806, pages 150854.
Crossref
Crossref
Amanda Honaker, Angela Kyntchev, Emma Foster, Katelyn Clough, Greg Hawk, Emmanuella Asiedu, Kevin Berling, Emma DeBurger, Mackenzie Feltner, Victoria Ferguson, Philip Tyler Forrest, Kayla Jenkins, Lisa Massie, Jayasree Mullaguru, Mame Diarra Niang, Connor Perry, Yvonne Sene, Aria Towell & Christine Perdan Curran. (2022) The behavioral effects of gestational and lactational benzo[a]pyrene exposure vary by sex and genotype in mice with differences at the Ahr and Cyp1a2 loci. Neurotoxicology and Teratology 89, pages 107056.
Crossref
Crossref
Yasuo Kurata, Shota Muraki, Takeshi Hirota, Hiroshi Araki & Ichiro Ieiri. (2021) Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic study. Drug Metabolism and Pharmacokinetics 41, pages 100403.
Crossref
Crossref
Waranya Chatuphonp, Nadta Sukkasem, Wipawee Tukum-mee, Jintanaporn Wattanatho & Kanokwan Jarukamjor. (2021) Impact of Pineapple on Mitochondrial Permeability Transition and Drug Metabolizing Genes in Caco-2 Cells. Pakistan Journal of Biological Sciences 24:12, pages 1217-1225.
Crossref
Crossref
Meredith R. McGuire, Debaditya Mukhopadhyay, Stephanie L. Myers, Eric P. Mosher, Rita T. Brookheart, Kai Kammers, Alfica Sehgal, Ebru S. Selen, Michael J. Wolfgang, Namandjé N. Bumpus & Peter J. Espenshade. (2021) Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism. Journal of Biological Chemistry 297:5, pages 101316.
Crossref
Crossref
Waranya Chatuphonp, Nadta Sukkasem, Isabella Ellinger & Kanokwan Jarukamjor. (2021) Plumbagin and Plumbago indica Differentially Modulated Cytochrome P450 and Transporter Profiles in BeWo and HepG2 Cells. Pakistan Journal of Biological Sciences 24:11, pages 1195-1201.
Crossref
Crossref
Jan Hálek, Jindřiška Voláková, Martin Wita, Jakub Lasák & Lumír Kantor. (2021) Caffeine, coffee, and breast-feeding. Pediatrie pro praxi 22:4, pages 272-275.
Crossref
Crossref
Navid Neyshaburinezhad, Hengameh Ghasim, Mohammadreza Rouini, Youssef Daali & Yalda H. Ardakani. (2021) Frequency of Important CYP450 Enzyme Gene Polymorphisms in the Iranian Population in Comparison with Other Major Populations: A Comprehensive Review of the Human Data. Journal of Personalized Medicine 11:8, pages 804.
Crossref
Crossref
Pasquale Paribello, Mirko Manchia, Massimo Zedda, Federica Pinna & Bernardo Carpiniello. (2021) Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature. Medicina 57:8, pages 816.
Crossref
Crossref
Masaki Kumondai, Evelyn Gutiérrez Rico, Eiji Hishinuma, Yuya Nakanishi, Shuki Yamazaki, Akiko Ueda, Sakae Saito, Shu Tadaka, Kengo Kinoshita, Daisuke Saigusa, Tomoki Nakayoshi, Akifumi Oda, Noriyasu Hirasawa & Masahiro Hiratsuka. (2021) Functional Characterization of 21 Rare Allelic CYP1A2 Variants Identified in a Population of 4773 Japanese Individuals by Assessing Phenacetin O-Deethylation. Journal of Personalized Medicine 11:8, pages 690.
Crossref
Crossref
Faten Farouk, Rawia M. Khalil, Ahmed Abdelbary, Silvia Kocova El Arini, Mona Basha & Hadeer A. El-Hashemy. (2020) Bioanalytical Comparison of Transdermal Delivery of Tizanidine from Different Nanovesicular Carriers. Journal of Pharmaceutical Innovation 16:2, pages 384-390.
Crossref
Crossref
Fernando de Andrés, Catalina Altamirano-Tinoco, Ronald Ramírez-Roa, Carlos F Montes-Mondragón, Pedro Dorado, Eva M. Peñas-Lledó & Adrián LLerena. (2020) Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population. The Pharmacogenomics Journal 21:2, pages 140-151.
Crossref
Crossref
Tawit Suriyo, Sadudee Chotirat, Nuchanart Rangkadilok, Nanthanit Pholphana & Jutamaad Satayavivad. (2021) Interactive effects of Andrographis paniculata extracts and cancer chemotherapeutic 5-Fluorouracil on cytochrome P450s expression in human hepatocellular carcinoma HepG2 cells. Journal of Herbal Medicine 26, pages 100421.
Crossref
Crossref
J. Patrick ConnickJames R. ReedGeorge F. CawleyWayne L. Backes. (2021) Heteromeric complex formation between human cytochrome P450 CYP1A1 and heme oxygenase-1. Biochemical Journal 478:2, pages 377-388.
Crossref
Crossref
Nina M. Pollak, Justin J. Cooper-White & Joanne Macdonald. (2021) Translational control of enzyme scavenger expression with toxin-induced micro RNA switches. Scientific Reports 11:1.
Crossref
Crossref
Rozalia-Maria Anastasiadi, Federico Berti, Silvia Colomban, Claudio Tavagnacco, Luciano Navarini & Marina Resmini. (2020) Simultaneous Quantification of Antioxidants Paraxanthine and Caffeine in Human Saliva by Electrochemical Sensing for CYP1A2 Phenotyping. Antioxidants 10:1, pages 10.
Crossref
Crossref
Florian Klomp, Christoph Wenzel, Marek Drozdzik & Stefan Oswald. (2020) Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes. Pharmaceutics 12:12, pages 1201.
Crossref
Crossref
Ádám Menus, Ádám Kiss, Katalin Tóth, Dávid Sirok, Máté Déri, Ferenc Fekete, Gábor Csukly & Katalin Monostory. (2020) Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophrenia. Scientific Reports 10:1.
Crossref
Crossref
Yasuo Kurata, Shota MurakiYushi KashiharaTakeshi HirotaHiroshi Araki & Ichiro Ieiri. (2020) Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis. Therapeutic Drug Monitoring 42:6, pages 829-834.
Crossref
Crossref
Sally Luvsantseren, Michelle Whirl-Carrillo, Katrin Sangkuhl, Nancy Shin, Alice Wen, Philip Empey, Benish Alam, Sean David, Henry M. Dunnenberger, Lori Orlando, Russ Altman & Latha Palaniappan. (2020) Variant Interpretation in Current Pharmacogenetic Testing. Journal of Personalized Medicine 10:4, pages 204.
Crossref
Crossref
Paul T. Kocis & Kent E. Vrana. (2020) Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical Cannabis and Cannabinoids 3:1, pages 61-73.
Crossref
Crossref
Marilyn C Cornelis, Sandra Weintraub & Martha Clare Morris. (2020) Caffeinated Coffee and Tea Consumption,Genetic Variation and Cognitive Function in the UK Biobank. The Journal of Nutrition 150:8, pages 2164-2174.
Crossref
Crossref
Marilyn C. Cornelis, Sandra Weintraub & Martha Clare Morris. (2020) Recent Caffeine Drinking Associates with Cognitive Function in the UK Biobank. Nutrients 12:7, pages 1969.
Crossref
Crossref
Weijiang Zhang, Christine McIntyre, Todd Riehl, Harper Forbes, Enric Bertran, Hye Jin Choi, Dae Ho Lee & Jeeyun Lee. (2020)
Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine (a CYP1A2 Substrate) in Patients With
BRAF
V600
Mutation–Positive Malignancies
. Clinical Pharmacology in Drug Development 9:5, pages 651-658.
Crossref
Crossref
Risto Olavi Juvonen, Elmeri Matias Jokinen, Adeel Javaid, Marko Lehtonen, Hannu Raunio & Olli Taneli Pentikäinen. (2020)
Inhibition of human CYP1 enzymes by a classical inhibitor α‐naphthoflavone and a novel inhibitor
N
‐(3, 5‐dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study
. Chemical Biology & Drug Design 95:5, pages 520-533.
Crossref
Crossref
František Perlík. (2020) Impact of smoking on metabolic changes and effectiveness of drugs used for lung cancer. Central European Journal of Public Health 28:1, pages 53-58.
Crossref
Crossref
Jingjing Qian, Qi Chen, Sean M. Ward, Enkui Duan & Ying Zhang. (2020) Impacts of Caffeine during Pregnancy. Trends in Endocrinology & Metabolism 31:3, pages 218-227.
Crossref
Crossref
Basu Dev Banerjee, Ranjeet Kumar, Krishna Latha Thamineni, Harendra Shah, Gaurav Kumar Thakur & Tusha Sharma. (2020) Effect of Environmental Exposure and Pharmacogenomics on Drug Metabolism. Current Drug Metabolism 20:14, pages 1103-1113.
Crossref
Crossref
Gaëlle Magliocco, Frédérique Rodieux, Jules Desmeules, Caroline Flora Samer & Youssef Daali. (2019) Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling. Pediatric Research 87:3, pages 441-449.
Crossref
Crossref
Waranya Chatuphonprasert, Tharita Kitisripanya, Waraporn Putalun, Isabella Ellinger & Kanokwan Jarukamjorn. (2020) Pueraria candollei var. mirifica-Induced CYP1A1 and CYP1A2 expression in human choriocarcinoma bewo cells. Pharmacognosy Magazine 16:5, pages 506.
Crossref
Crossref
K. Yu. Lukianets & M.L. Lyndina. (2020) ASSOCIATION BETWEEN SMOKING AND THE ANTIPLATELET EFFECT OF CLOPIDOGREL. Juvenis Scientia 6:5, pages 14-24.
Crossref
Crossref
Marco E. Franco, Grace E. Sutherland, Maria T. Fernandez-Luna & Ramon Lavado. (2020) Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS). Toxicology 430, pages 152339.
Crossref
Crossref
Jian Lu, Xuyang Shang, Weiguo Zhong, Yuan Xu, Rong Shi & Xin Wang. (2020) New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases. Acta Pharmaceutica Sinica B 10:1, pages 91-104.
Crossref
Crossref
Laith N. AL-Eitan, Doaa M. Rababa’h, Mansour A. Alghamdi & Rame H. Khasawneh. (2019) Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population. BMC Medical Genetics 20:1.
Crossref
Crossref
Ken Ogasawara, Kimberly MacGorman, Liangang Liu, Jian Chen, Leonidas N. Carayannopoulos, Simon Zhou, Maria Palmisano & Yan Li. (2019) Drug‐Drug Interaction Study to Assess the Effect of Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of the Novel Cereblon Modulator Avadomide (CC‐122) in Healthy Adult Subjects. The Journal of Clinical Pharmacology 59:12, pages 1620-1631.
Crossref
Crossref
Nupur S. Munjal, Rohit Shukla & Tiratha Raj Singh. (2019) Chemometric approach to estimate kinetic properties of paclitaxel prodrugs and their substructures for solubility prediction through molecular modelling and simulation studies. Journal of Chemometrics 33:11.
Crossref
Crossref
Xinyi Li, Dongzhen Yu, Huiqun Jie, Huiqun Zhou, Haibo Ye, Guo Ma, Lili Wan, Chunyan Li, Haibo Shi & Shankai Yin. (2019) Cytochrome P450 1A2 Is Incapable of Oxidizing Bilirubin Under Physiological Conditions. Frontiers in Pharmacology 10.
Crossref
Crossref
Yaohua Yang, Xiang Shu, Xiao-ou Shu, Manjeet K. Bolla, Sun-Seog Kweon, Qiuyin Cai, Kyriaki Michailidou, Qin Wang, Joe Dennis, Boyoung Park, Keitaro Matsuo, Ava Kwong, Sue Kyung Park, Anna H. Wu, Soo Hwang Teo, Motoki Iwasaki, Ji-Yeob Choi, Jingmei Li, Mikael Hartman, Chen-Yang Shen, Kenneth Muir, Artitaya Lophatananon, Bingshan Li, Wanqing Wen, Yu-Tang Gao, Yong-Bing Xiang, Kristan J. Aronson, John J. Spinell, Manuela Gago-Dominguez, Esther M. John, Allison W. Kurian, Jenny Chang-Claude, Shou-Tung Chen, Thilo Dörk, D. Gareth R. Evans, Marjanka K. Schmidt, Min-Ho Shin, Graham G. Giles, Roger L. Milne, Jacques Simard, Michiaki Kubo, Peter Kraft, Daehee Kang, Douglas F. Easton, Wei Zheng & Jirong Long. (2019) Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine 48, pages 203-211.
Crossref
Crossref
Jinyun Dong, Guang Huang, Qijing Zhang, Zengtao Wang, Jiahua Cui, Yan Wu, Qingqing Meng & Shaoshun Li. (2019) Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents. MedChemComm 10:9, pages 1606-1614.
Crossref
Crossref
Elias Begas, Maria Bounitsi, Thomas Kilindris, Evangelos Kouvaras, Konstantinos Makaritsis, Demetrios Kouretas & Eftihia K. Asprodini. (2019) Effects of short-term saffron (Crocus sativus L.) intake on the in vivo activities of xenobiotic metabolizing enzymes in healthy volunteers. Food and Chemical Toxicology 130, pages 32-43.
Crossref
Crossref
Ziru Dai, Guibo Sun, Jiada Yang, Jie Hou, Ping Zhou, Weijie Xie, Guangbo Ge, Xiaobo Sun & Ling Yang. (2019) Interspecies Variation in NCMN-O-Demethylation in Liver Microsomes from Various Species. Molecules 24:15, pages 2765.
Crossref
Crossref
Jonathan M. Meyer & Stephen M. Stahl. 2021. The Clozapine Handbook. The Clozapine Handbook
90
113
.
Tacy Santana Machado, Claire Cerini & Stéphane Burtey. (2019) Emerging Roles of Aryl Hydrocarbon Receptors in the Altered Clearance of Drugs during Chronic Kidney Disease. Toxins 11:4, pages 209.
Crossref
Crossref
Zhiyan Liu, Qian Xiang, Guangyan Mu, Qiufen Xie, Shuang Zhou, Zining Wang, Shuqing Chen, Kun Hu, Yanjun Gong, Jie Jiang & Yimin Cui. (2019) Effectiveness and Safety of Platelet ADP–P2Y12 Receptor Inhibitors Influenced by Smoking Status: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association 8:7.
Crossref
Crossref
Yuhao Zhu, Naixing Zhang, Decheng Ren, Yan Bi, Fei Xu, Weibo Niu, Qianqian Sun, Zhenming Guo, Ruixue Yuan, Fan Yuan, Xi Wu, Yanfei Cao, Fengping Yang, Lu Wang, Li Du, Weidong Li, Yifeng Xu, Xingwang Li, Liping Zhu, Lin He, Lei Shi, Guang He & Tao Yu. (2019) CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population. Clinical Neuropharmacology 42:2, pages 32-36.
Crossref
Crossref
M. Na Takuathung, N. Hanprasertpong, S. Teekachunhatean & N. Koonrungsesomboon. (2018)
Impact of
CYP1A2
genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta‐analysis
. Acta Psychiatrica Scandinavica 139:1, pages 15-25.
Crossref
Crossref
Nut Koonrungsesomboon, Rapheephorn Khatsri, Penwisa Wongchompoo & Supanimit Teekachunhatean. (2017) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. The Pharmacogenomics Journal 18:6, pages 760-768.
Crossref
Crossref
Justin D. Lutz, Brian J. Kirby, Lu Wang, Qinghua Song, John Ling, Benedetta Massetto, Angela Worth, Brian P. Kearney & Anita Mathias. (2018) Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 1: Establishing Induction Relationships Using Ascending Dose Rifampin. Clinical Pharmacology & Therapeutics 104:6, pages 1182-1190.
Crossref
Crossref
Justin D. Lutz, Brian J. Kirby, Lu Wang, Qinghua Song, John Ling, Benedetta Massetto, Angela Worth, Brian P. Kearney & Anita Mathias. (2018) Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine. Clinical Pharmacology & Therapeutics 104:6, pages 1191-1198.
Crossref
Crossref
Dakota L. Pouncey, Jessica H. Hartman, Page C. Moore, David J. Dillinger, Kimberly W. Dickerson, Daniel R. Sappington, Eugene S. Smith, Gunnar Boysen & Grover P. Miller. (2018) Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients. Blood Coagulation & Fibrinolysis 29:7, pages 602-612.
Crossref
Crossref
Wiebe Braam, Friederike Ehrhart, Anneke P.H.M. Maas, Marcel G. Smits & Leopold Curfs. (2018) Low maternal melatonin level increases autism spectrum disorder risk in children. Research in Developmental Disabilities 82, pages 79-89.
Crossref
Crossref
Simon Taylor. 2018. Early Drug Development. Early Drug Development
603
630
.
Katherine S Koch, Tom Moran, W Thomas Shier & Hyam L Leffert. (2018) N-Acetyl-2-Aminofluorene (AAF) Processing in Adult Rat Hepatocytes in Primary Culture Occurs by High-Affinity Low-Velocity and Low-Affinity High-Velocity AAF Metabolite-Forming Systems. Toxicological Sciences 163:1, pages 26-34.
Crossref
Crossref
Sanna Rauhamäki, Pekka A. Postila, Sanna Niinivehmas, Sami Kortet, Emmi Schildt, Mira Pasanen, Elangovan Manivannan, Mira Ahinko, Pasi Koskimies, Niina Nyberg, Pasi Huuskonen, Elina Multamäki, Markku Pasanen, Risto O. Juvonen, Hannu Raunio, Juhani Huuskonen & Olli T. Pentikäinen. (2018) Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors. Frontiers in Chemistry 6.
Crossref
Crossref
Barbara M. Zietek, Marija Mladic, Ben Bruyneel, Wilfried M.A. Niessen, Maarten Honing, Govert W. Somsen & Jeroen Kool. (2018) Nanofractionation Platform with Parallel Mass Spectrometry for Identification of CYP1A2 Inhibitors in Metabolic Mixtures. SLAS Discovery 23:3, pages 283-293.
Crossref
Crossref
Aleksi Tornio & Janne T. Backman. 2018. Pharmacogenetics. Pharmacogenetics
3
32
.
Vivek Chowdhary, Kun-yu Teng, Sharda Thakral, Bo Zhang, Cho-hao Lin, Nissar Wani, Lei Bruschweiler-Li, Xiaoli Zhang, Laura James, Dakai Yang, Norman Junge, Rafael Brüschweiler, William M. Lee & Kalpana Ghoshal. (2017) miRNA-122 Protects Mice and Human Hepatocytes from Acetaminophen Toxicity by Regulating Cytochrome P450 Family 1 Subfamily A Member 2 and Family 2 Subfamily E Member 1 Expression. The American Journal of Pathology 187:12, pages 2758-2774.
Crossref
Crossref
Phisit Pouyfung, Songklod Sarapusit & Pornpimol Rongnoparut. (2017)
Effects of
Vernonia cinerea
Compounds on Drug-metabolizing Cytochrome P450s in Human Liver Microsomes
. Phytotherapy Research 31:12, pages 1916-1925.
Crossref
Crossref
Marta Batllori, Marta Molero-Luis, Luisa Arrabal, Javier de las Heras, Joaquín-Alejandro Fernandez-Ramos, Luis González Gutiérrez-Solana, Salvador Ibáñez-Micó, Rosario Domingo, Jaume Campistol, Aida Ormazabal, Frederic Sedel, Thomas Opladen, Basiliki Zouvelou, Roser Pons, Angels Garcia-Cazorla, Eduardo Lopez-Laso & Rafael Artuch. (2017) Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients. Scientific Reports 7:1.
Crossref
Crossref
Fernando de AndrésMartha Sosa-MacíasBlanca Patricia Lazalde RamosMaría-Eugenia G. NaranjoAdrián LLerena. (2017) CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations–Where to from Here for Global Precision Medicine?. OMICS: A Journal of Integrative Biology 21:9, pages 509-519.
Crossref
Crossref
George Banis, Thomas Winkler, Patricia Barton, Sheryl Chocron, Eunkyoung Kim, Deanna Kelly, Gregory Payne, Hadar Ben-Yoav & Reza Ghodssi. (2017) The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case Study. Pharmaceuticals 10:4, pages 69.
Crossref
Crossref
Edoardo Casiglia, Valérie Tikhonoff, Federica Albertini, Jacopo Favaro, Martina Montagnana, Elisa Danese, Francesco Finatti, Marco Benati, Alberto Mazza, Lucia Dal Maso, Paolo Spinella & Paolo Palatini. (2017) Caffeine intake and abstract reasoning among 1374 unselected men and women from general population. Role of the –163C>A polymorphism of CYP1A2 gene. Clinical Nutrition ESPEN 20, pages 52-59.
Crossref
Crossref
Jayalakshmi Sridhar, Navneet Goyal, Jiawang Liu & Maryam Foroozesh. (2017) Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date. Molecules 22:7, pages 1143.
Crossref
Crossref
Ilanna Campelo Lopes & Ana Maria Oliveira-Brett. (2017)
Human Cytochrome P450 (CYP1A2)-dsDNA Interaction
in situ
Evaluation Using a dsDNA-electrochemical Biosensor
. Electroanalysis 29:7, pages 1674-1682.
Crossref
Crossref
Ahmed Elkamhawy, Jung-eun Park, Ahmed H.E. Hassan, Ae Nim Pae, Jiyoun Lee, Beoung-Geon Park, Sora Paik, Jimin Do, Jong-Hyun Park, Ki Duk Park, Bongjin Moon, Woo Kyu Park, Heeyeong Cho, Dae Young Jeong & Eun Joo Roh. (2017) Design, synthesis, biological evaluation and molecular modelling of 2-(2-aryloxyphenyl)-1,4-dihydroisoquinolin-3(2 H )-ones: A novel class of TSPO ligands modulating amyloid-β-induced mPTP opening. European Journal of Pharmaceutical Sciences 104, pages 366-381.
Crossref
Crossref
Masahiro Iseki, Yoshihiro Kushida, Shohei Wakao, Takahiro Akimoto, Masamichi Mizuma, Fuyuhiko Motoi, Ryuta Asada, Shinobu Shimizu, Michiaki Unno, Gregorio Chazenbalk & Mari Dezawa. (2017) Human Muse Cells, Nontumorigenic Phiripotent-Like Stem Cells, Have Liver Regeneration Capacity through Specific Homing and Cell Replacement in a Mouse Model of Liver Fibrosis. Cell Transplantation 26:5, pages 821-840.
Crossref
Crossref
David J. Greenblatt. (2017) Mechanisms and Consequences of Drug-Drug Interactions. Clinical Pharmacology in Drug Development 6:2, pages 118-124.
Crossref
Crossref
Ariane R. Guthrie, H-H. Sherry Chow & Jessica A. Martinez. (2017) Effects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention. Pharmacology Research & Perspectives 5:1, pages e00294.
Crossref
Crossref
Elena Puris, Markku Pasanen, Mikko Gynther, Merja R. Häkkinen, Jussi Pihlajamäki, Tapani Keränen, Paavo Honkakoski, Hannu Raunio & Aleksanteri Petsalo. (2016) A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urine. Analytical and Bioanalytical Chemistry 409:1, pages 251-268.
Crossref
Crossref
Cédric Galéra, Jonathan Y. Bernard, Judith van der Waerden, Manuel-Pierre Bouvard, Sandrine Lioret, Anne Forhan, Maria De Agostini, Maria Melchior & Barbara Heude. (2016) Prenatal Caffeine Exposure and Child IQ at Age 5.5 Years: The EDEN Mother-Child Cohort. Biological Psychiatry 80:9, pages 720-726.
Crossref
Crossref
Gail D. Anderson & Lingtak-Neander Chan. (2016) Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products. Clinical Pharmacokinetics 55:11, pages 1353-1368.
Crossref
Crossref
Jinyun Dong, Qijing Zhang, Qing Cui, Guang Huang, Xiaoyan Pan & Shaoshun Li. (2016) Flavonoids and Naphthoflavonoids: Wider Roles in the Modulation of Cytochrome P450 Family 1 Enzymes. ChemMedChem 11:19, pages 2102-2118.
Crossref
Crossref
Eunkyoung Kim, Yi Liu, Hadar Ben‐Yoav, Thomas E. Winkler, Kun Yan, Xiaowen Shi, Jana Shen, Deanna L. Kelly, Reza Ghodssi, William E. Bentley & Gregory F. Payne. (2016) Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels. Advanced Healthcare Materials 5:20, pages 2595-2616.
Crossref
Crossref
M.L. Perepechaeva, N.G. Kolosova, N.A. Stefanova, A.Zh. Fursova & A.Y. Grishanova. (2016) The influence of changes in expression of redox-sensitive genes on the development of retinopathy in rats. Experimental and Molecular Pathology 101:1, pages 124-132.
Crossref
Crossref
Kenta Haraya, Motohiro Kato, Koji Chiba & Yuichi Sugiyama. (2016) Prediction of inter-individual variability on the pharmacokinetics of CYP1A2 substrates in non-smoking healthy volunteers. Drug Metabolism and Pharmacokinetics 31:4, pages 276-284.
Crossref
Crossref
Xiling Jiang, Yanli Zhuang, Zhenhua Xu, Weirong Wang & Honghui Zhou. (2016) Development of a Physiologically Based Pharmacokinetic Model to Predict Disease-Mediated Therapeutic Protein–Drug Interactions: Modulation of Multiple Cytochrome P450 Enzymes by Interleukin-6. The AAPS Journal 18:3, pages 767-776.
Crossref
Crossref
Li Liu, Ming-xing Miao, Ze-yu Zhong, Ping Xu, Yang Chen & Xiao-dong Liu. (2016) Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats. Acta Pharmacologica Sinica 37:4, pages 561-570.
Crossref
Crossref
Natasa Djordjevic, Dragana Dragas Milovanovic, Marija Radovanovic, Ivan Radosavljevic, Slobodan Obradovic, Mihajlo Jakovljevic, Dragan Milovanovic, Jasmina R. Milovanovic & Slobodan Jankovic. (2016) CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy. European Journal of Clinical Pharmacology 72:4, pages 439-445.
Crossref
Crossref
G.-Z. Qi, Z.-Y. Zhang, X. Wang, S.-J. Yin, Y.-Q. Lou & G.-L. Zhang. (2016)
Functional allele and genotype frequencies of
CYP1A2
,
CYP2B6
and
iNOS
among mainland Chinese Tibetan, Mongolian, Uygur and Han populations
. Journal of Clinical Pharmacy and Therapeutics 41:1, pages 84-91.
Crossref
Crossref
Sun-Mi ChoKyung-Yul LeeJong Rak ChoiKyung-A Lee. (2016) Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients. Yonsei Medical Journal 57:3, pages 635.
Crossref
Crossref
Salah A. Sheweita, Mona Wally & Mostafa Hassan. (2016) Erectile Dysfunction Drugs Changed the Protein Expressions and Activities of Drug-Metabolising Enzymes in the Liver of Male Rats. Oxidative Medicine and Cellular Longevity 2016, pages 1-9.
Crossref
Crossref
Petr Jeřábek, Jan Florián & Václav Martínek. (2016) Lipid molecules can induce an opening of membrane-facing tunnels in cytochrome P450 1A2. Physical Chemistry Chemical Physics 18:44, pages 30344-30356.
Crossref
Crossref
John Lally & Robert J. Flanagan. 2016. Life-Threatening Effects of Antipsychotic Drugs. Life-Threatening Effects of Antipsychotic Drugs
105
148
.
T. Matakova, E. Halasova, A. Dzian, R. Hruby, M. Halasa, K. Javorka & M. Skerenova. 2016. Advances in Respiratory Cancerogenesis. Advances in Respiratory Cancerogenesis
23
32
.
Marianna Stamou, Eric Uwimana, Brenna M. Flannery, Izabela Kania-Korwel, Hans-Joachim Lehmler & Pamela J. Lein. (2015) Subacute nicotine co-exposure has no effect on 2,2′,3,5′,6- pentachlorobiphenyl disposition but alters hepatic cytochrome P450 expression in the male rat. Toxicology 338, pages 59-68.
Crossref
Crossref
Kristina K. Wolf, Brandon T. Gufford, Scott J. Brantley, Paul B. Watkins & Mary F. Paine. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
626
638
.
Simon J. TaylorEmmanuel H. DemontJames GrayNigel DeeksAarti PatelDung Nguyen, Maxine TaylorSteve HoodRobert J. WatsonRino A. BitFiona McClureHolly AshallJason Witherington. (2015)
Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P
1
Agonists
. Journal of Medicinal Chemistry 58:20, pages 8236-8256.
Crossref
Crossref
Robert J. Turesky, Kami K. White, Lynne R. Wilkens & Loïc Le Marchand. (2015) Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans. Chemical Research in Toxicology 28:8, pages 1603-1615.
Crossref
Crossref
Soon Sang Kwon, Ju Hyun Kim, Hyeon-Uk Jeong, Kyung-Seop Ahn, Sei-Ryang Oh & Hye Suk Lee. (2015) Role of cytochrome P450 and UDP-glucuronosyltransferases in metabolic pathway of homoegonol in human liver microsomes. Drug Metabolism and Pharmacokinetics 30:4, pages 305-313.
Crossref
Crossref
Hannu Raunio, Mira Kuusisto, Risto O. Juvonen & Olli T. Pentikäinen. (2015) Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes. Frontiers in Pharmacology 6.
Crossref
Crossref
P. Wang, L. Ouyang, L. Zheng & Z. Wang. (2014) Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis. Irish Journal of Medical Science (1971 -) 184:2, pages 357-364.
Crossref
Crossref
A. T. Nordestgaard, M. Thomsen & B. G. Nordestgaard. (2015) Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. International Journal of Epidemiology 44:2, pages 551-565.
Crossref
Crossref
Eunkyoung Kim, Sheryl E. Chocron, Hadar Ben-Yoav, Thomas E. Winkler, Yi Liu, Matthew Glassman, Christopher Wolfram, Deanna L. Kelly, Reza Ghodssi & Gregory F. Payne. (2015) Programmable “Semismart” Sensor: Relevance to Monitoring Antipsychotics. Advanced Functional Materials 25:14, pages 2156-2165.
Crossref
Crossref
Marilyn C. Cornelis. (2015) Toward systems epidemiology of coffee and health. Current Opinion in Lipidology 26:1, pages 20-29.
Crossref
Crossref
Alexandre F. Aissa & Lusânia M.G. Antunes. 2015. Personalized Epigenetics. Personalized Epigenetics
245
282
.
Jingjing Yan, Xin He, Shan Feng, Yiran Zhai, Yetao Ma, Sheng Liang & Chunhuan Jin. (2014) Up-regulation on cytochromes P450 in rat mediated by total alkaloid extract from Corydalis yanhusuo. BMC Complementary and Alternative Medicine 14:1.
Crossref
Crossref
Neil R. Hartman, Jinzhe J. Mao, Hongfei Zhou, Michael T. BoyneIIII, Adam M. Wasserman, Kellie Taylor, Judith A. Racoosin, Vikram Patel & Thomas Colatsky. (2014) More methemoglobin is produced by benzocaine treatment than lidocaine treatment in human in vitro systems. Regulatory Toxicology and Pharmacology 70:1, pages 182-188.
Crossref
Crossref
Yan Pan, Kai Hung Tiong, Badrul Amini Abd-Rashid, Zakiah Ismail, Rusli Ismail, Joon Wah Mak & Chin Eng Ong. (2014) In vitro effect of important herbal active constituents on human cytochrome P450 1A2 (CYP1A2) activity. Phytomedicine 21:12, pages 1645-1650.
Crossref
Crossref
C. Kragelund, S.B. Jensen, C. Hansen Cand Scient, K. Broesen, L.A. Torpet & J. Reibel. (2014) Subgrouping of patients with oral lichen planus according to cytochrome P450 enzyme phenotype and genotype. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 118:4, pages 469-474.
Crossref
Crossref
Marlon J.A. Jetten, Sandra M. Claessen, Cornelis H.C. Dejong, Agustin Lahoz, José V. Castell, Joost H.M. van Delft & Jos C.S. Kleinjans. (2014) Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices. Toxicology 323, pages 61-69.
Crossref
Crossref
Marilyn C. Cornelis. (2014) Gene-Coffee Interactions and Health. Current Nutrition Reports 3:3, pages 178-195.
Crossref
Crossref
Gillian G Johnson, Daniel F Carr, Munir Pirmohamed & Andrew R Pettitt. (2014) Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?. Pharmacogenomics 15:7, pages 897-900.
Crossref
Crossref
Anthony A. Estrada, Bryan K. Chan, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Huifen Chen, Sara L. Dominguez, Jennafer Dotson, Jason Drummond, Michael Flagella, Reina Fuji, Andrew Gill, Jason Halladay, Seth F. Harris, Timothy P. Heffron, Tracy Kleinheinz, Donna W. Lee, Claire E. Le Pichon, Xingrong Liu, Joseph P. Lyssikatos, Andrew D. Medhurst, John G. Moffat, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Susan Wong, Shuo Zhang, Xiaolin Zhang, Haitao Zhu & Zachary K. Sweeney. (2014) Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. Journal of Medicinal Chemistry 57:3, pages 921-936.
Crossref
Crossref
Xue Qiao, Shuai Ji, Si-wang Yu, Xiong-hao Lin, Hong-wei Jin, Yao-kai Duan, Liang-ren Zhang, De-an Guo & Min Ye. (2013) Identification of Key Licorice Constituents Which Interact with Cytochrome P450: Evaluation by LC/MS/MS Cocktail Assay and Metabolic Profiling. The AAPS Journal 16:1, pages 101-113.
Crossref
Crossref
D. Fanni, R. Ambu, C. Gerosa, S. Nemolato, M. Castagnola, P. Van Eyken, G. Faa & V. Fanos. (2014) Cytochrome P450 Genetic Polymorphism in Neonatal Drug Metabolism: Role and Practical Consequences towards a New Drug Culture in Neonatology. International Journal of Immunopathology and Pharmacology 27:1, pages 5-13.
Crossref
Crossref
Allan E. Rettie & Kenneth E. Thummel. 2014. Fifty Years of Cytochrome P450 Research. Fifty Years of Cytochrome P450 Research
371
401
.
Jiawang Liu, Jayalakshmi Sridhar & Maryam Foroozesh. (2013) Cytochrome P450 Family 1 Inhibitors and Structure-Activity Relationships. Molecules 18:12, pages 14470-14495.
Crossref
Crossref
M.J.A. Jetten, J.C.S. Kleinjans, S.M. Claessen, C. Chesné & J.H.M. van Delft. (2013) Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes. Toxicology in Vitro 27:7, pages 2031-2040.
Crossref
Crossref
Jinzhong Liu, Peter J. Flockhart, Deshun Lu, Wei Lv, Wenjie Jessie Lu, Xu Han, Mark Cushman & David A. Flockhart. (2013)
Inhibition of Cytochrome P450 Enzymes by the
E
- and
Z
-Isomers of Norendoxifen
. Drug Metabolism and Disposition 41:9, pages 1715-1720.
Crossref
Crossref
Hsiang-Wei Kuo, Shu Chih Liu, Hsiao-Hui Tsou, Sheng-Wen Liu, Keh-Ming Lin, Shao-Chun Lu, Mei-Chun Hsiao, Chin-Fu Hsiao, Chia-Yih Liu, Chia-Hui Chen, Mong-Liang Lu, Winston W Shen, Hwa-Sheng TangShen-Ing Liu, Liang-Huey Chang, Hsiao-Yu Wu, Yao-Sheng Chang, Teng-Kuang Yeh, Andrew CH Chen & Yu-Li Liu. (2013)
CYP1A2
genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
. Pharmacogenomics 14:10, pages 1191-1201.
Crossref
Crossref
Nancy Légaré, Claire-Anne Grégoire, Luigi De Benedictis & Alexandre Dumais. (2013) Increasing the clozapine: Norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy. Medical Hypotheses 80:6, pages 689-691.
Crossref
Crossref
Maria Dobrinas, Jacques Cornuz & Chin B. Eap. (2013) Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers. Pharmacogenetics and Genomics 23:5, pages 286-292.
Crossref
Crossref
Kevin P. Bliden, Brian A. Baker, Thomas D. Nolin, Young-Hoon Jeong, William L. Bailey, Udaya S. Tantry & Paul A. Gurbel. (2013) Thienopyridine efficacy and cigarette smoking status. American Heart Journal 165:5, pages 693-703.
Crossref
Crossref
Kristopher J. Swiger, Omair Yousuf, Kevin P. Bliden, Udaya S. Tantry & Paul A. Gurbel. (2013) Cigarette Smoking and Clopidogrel Interaction. Current Cardiology Reports 15:5.
Crossref
Crossref
Liqing Wang, Zheyi Hu, Xun Deng, Yong Wang, Zhongyi Zhang & Ze‐Neng Cheng. (2012)
Association between Common
CYP
1
A
2
Polymorphisms and Theophylline Metabolism in Non‐smoking Healthy Volunteers
. Basic & Clinical Pharmacology & Toxicology 112:4, pages 257-263.
Crossref
Crossref
Ulrich M. Zanger & Matthias Schwab. (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics 138:1, pages 103-141.
Crossref
Crossref
Yitong Liu, Thomas J. Flynn, Martine S. Ferguson & Erica M. Hoagland. (2013) Use of the Combination Index to determine interactions between plant-derived phenolic acids on hepatotoxicity endpoints in human and rat hepatoma cells. Phytomedicine 20:5, pages 461-468.
Crossref
Crossref
Wan-Ting Hung, George H. Lambert, Ping-Wei Huang, Donald G. PattersonJr.Jr. & Yue Leon Guo. (2013) Genetic susceptibility to dioxin-like chemicals’ induction of cytochrome P4501A2 in the human adult linked to specific AhRR polymorphism. Chemosphere 90:9, pages 2358-2364.
Crossref
Crossref
Anto P. Rajkumar, B. Poonkuzhali, Anju Kuruvilla, Alok Srivastava, Molly Jacob & K. S. Jacob. (2013)
Association between
CYP1A2
gene single nucleotide polymorphisms and clinical responses to clozapine in patients with treatment-resistant schizophrenia
. Acta Neuropsychiatrica 25:1, pages 2-11.
Crossref
Crossref
Bryan K. Chan, Anthony A. Estrada, Huifen Chen, John Atherall, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Sara L. Dominguez, Jason Drummond, Andrew Gill, Tracy Kleinheinz, Claire E. Le Pichon, Andrew D. Medhurst, Xingrong Liu, John G. Moffat, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Hervé Van de Poël, Shuo Zhang, Haitao Zhu & Zachary K. Sweeney. (2012) Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor. ACS Medicinal Chemistry Letters 4:1, pages 85-90.
Crossref
Crossref
M. D. Ronquillo-Sánchez, R. Camacho-Carranza, C. Fernandez-Mejia, S. Hernández-Ojeda, M. Elinos-Baez & J. J. Espinosa-Aguirre. (2013) Modulation of the Rat Hepatic Cytochrome P4501A Subfamily Using Biotin Supplementation. BioMed Research International 2013, pages 1-9.
Crossref
Crossref
Misaki Kojima & Masakuni Degawa. (2013) Serum androgen level is determined by autosomal dominant inheritance and regulates sex-related CYP genes in pigs. Biochemical and Biophysical Research Communications 430:2, pages 833-838.
Crossref
Crossref
Anthony A. Estrada, Xingrong Liu, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Bryan K. Chan, Huifen Chen, Xiao Ding, Antonio G. DiPasquale, Sara L. Dominguez, Jennafer Dotson, Jason Drummond, Michael Flagella, Sean Flynn, Reina Fuji, Andrew Gill, Janet Gunzner-Toste, Seth F. Harris, Timothy P. Heffron, Tracy Kleinheinz, Donna W. Lee, Claire E. Le Pichon, Joseph P. Lyssikatos, Andrew D. Medhurst, John G. Moffat, Susmith Mukund, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Thuy Tran, Naimisha Trivedi, Shumei Wang, Shuo Zhang, Xiaolin Zhang, Guiling Zhao, Haitao Zhu & Zachary K. Sweeney. (2012) Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. Journal of Medicinal Chemistry 55:22, pages 9416-9433.
Crossref
Crossref
Sofia Pavanello. (2012) Role of CYP1A2 polymorphisms in breast cancer risk in women. Molecular Medicine Reports.
Crossref
Crossref
Lei Hu, Wei Zhuo, Yi-Jing He, Hong-Hao Zhou & Lan Fan. (2012) Pharmacogenetics of P450 oxidoreductase. Pharmacogenetics and Genomics 22:11, pages 812-819.
Crossref
Crossref
William P. Petros, Islam R. Younis, James N. Ford & Scott A. Weed. (2012) Effects of Tobacco Smoking and Nicotine on Cancer Treatment. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:10, pages 920-931.
Crossref
Crossref
S. Olguín-Reyes, R. Camacho-Carranza, S. Hernández-Ojeda, M. Elinos-Baez & J.J. Espinosa-Aguirre. (2012) Bergamottin is a competitive inhibitor of CYP1A1 and is antimutagenic in the Ames test. Food and Chemical Toxicology 50:9, pages 3094-3099.
Crossref
Crossref
Janet Morffi, Idania Rodeiro, Sandra Luz Hernández, Leonora González, Jose Herrera & J. Javier Espinosa-Aguirre. (2012) Antimutagenic Properties of Mangifera indica L. Stem Bark Extract and Evaluation of its Effects on Hepatic CYP1A1. Plant Foods for Human Nutrition 67:3, pages 223-228.
Crossref
Crossref
W. Braam, H. Keijzer, H. Struijker Boudier, R. Didden, M. Smits & L. Curfs. (2012) CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?. Journal of Intellectual Disability Research, pages no-no.
Crossref
Crossref
Idris Guessous, Maria Dobrinas, Zoltán Kutalik, Menno Pruijm, Georg Ehret, Marc Maillard, Sven Bergmann, Jacques S. Beckmann, Daniele Cusi, Federica Rizzi, Franco Cappuccio, Jacques Cornuz, Fred Paccaud, Vincent Mooser, Jean-Michel Gaspoz, Gérard Waeber, Michel Burnier, Peter Vollenweider, Chin B Eap & Murielle Bochud. (2012) Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension. Human Molecular Genetics 21:14, pages 3283-3292.
Crossref
Crossref
Sofia Pavanello, Ugo Fedeli, Giuseppe Mastrangelo, Federica Rota, Kim Overvad, Ole Raaschou-Nielsen, Anne Tjønneland & Ulla Vogel. (2012) Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. Cancer Genetics 205:6, pages 278-284.
Crossref
Crossref
Zdenek Dvorak. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
223
258
.
Maria Dobrinas, Jacques Cornuz, Leticia Pedrido & Chin B. Eap. (2012) Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking. Pharmacogenetics and Genomics 22:2, pages 143-151.
Crossref
Crossref
Ahmed Faizal Abdull Razis, Gina Rosalinda De Nicola, Eleonora Pagnotta, Renato Iori & Costas Ioannides. (2011) 4-Methylsulfanyl-3-butenyl isothiocyanate derived from glucoraphasatin is a potent inducer of rat hepatic phase II enzymes and a potential chemopreventive agent. Archives of Toxicology 86:2, pages 183-194.
Crossref
Crossref
David J. Edwards. 2012. Pharmacotherapy of Child and Adolescent Psychiatric Disorders. Pharmacotherapy of Child and Adolescent Psychiatric Disorders
51
63
.
Samanta Yubero-Lahoz, Ricardo Pardo, Magí Farre, Brian Ó Mathuna, Marta Torrens, Cristina Mustata, Clara Perez-Mañá, Klaus Langohr, Marcel-lí Carbó & Rafael de la Torre. (2012) Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug. Drug Metabolism and Pharmacokinetics 27:6, pages 605-613.
Crossref
Crossref
Marilyn C. Cornelis. 2012. Recent Advances in Nutrigenetics and Nutrigenomics. Recent Advances in Nutrigenetics and Nutrigenomics
293
322
.
Ying Guo, Chad Pope, Xingguo Cheng, Honghao Zhou & Curtis D. Klaassen. (2011) Dose–response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. Journal of Ethnopharmacology 138:1, pages 111-118.
Crossref
Crossref
Shinji Tanaka, Kaoru Mogushi, Mahmut Yasen, Daisuke Ban, Norio Noguchi, Takumi Irie, Atsushi Kudo, Noriaki Nakamura, Hiroshi Tanaka, Masakazu Yamamoto, Norihiro Kokudo, Tadatoshi Takayama, Seiji Kawasaki, Michiie Sakamoto & Shigeki Arii. (2011) Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: A prospective, multicenter study. Hepatology 54:4, pages 1273-1281.
Crossref
Crossref
Paola Di Gion, Friederike Kanefendt, Andreas Lindauer, Matthias Scheffler, Oxana Doroshyenko, Uwe Fuhr, Jürgen Wolf & Ulrich Jaehde. (2011) Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors. Clinical Pharmacokinetics 50:9, pages 551-603.
Crossref
Crossref
Maxine X. Patel, Sally Bowskill, Lewis Couchman, Victoria Lay, David Taylor, Edgar Pathrose Spencer & Robert James Flanagan. (2011) Plasma Olanzapine in Relation to Prescribed Dose and Other Factors. Journal of Clinical Psychopharmacology 31:4, pages 411-417.
Crossref
Crossref
M Dobrinas, J Cornuz, B Oneda, M Kohler Serra, M Puhl & C B Eap. (2011) Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility. Clinical Pharmacology & Therapeutics 90:1, pages 117-125.
Crossref
Crossref
Kyung-Hee Noh, Kwan-Hee Min, Bo-Young Seo, Hye-Ok Kim, So-Hee Kim & Young-Sun Song. (2011) Suppressive Effects of Defatted Green Tea Seed Ethanol Extract on Cancer Cell Proliferation in HepG2 Cells. Journal of the Korean Society of Food Science and Nutrition 40:6, pages 767-774.
Crossref
Crossref
M Kacevska, M Ivanov & M Ingelman-Sundberg. (2011) Perspectives on Epigenetics and Its Relevance to Adverse Drug Reactions. Clinical Pharmacology & Therapeutics 89:6, pages 902-907.
Crossref
Crossref
Marilyn C. Cornelis, Keri L. Monda, Kai Yu, Nina Paynter, Elizabeth M. Azzato, Siiri N. Bennett, Sonja I. Berndt, Eric Boerwinkle, Stephen Chanock, Nilanjan Chatterjee, David Couper, Gary Curhan, Gerardo Heiss, Frank B. Hu, David J. Hunter, Kevin Jacobs, Majken K. Jensen, Peter Kraft, Maria Teresa Landi, Jennifer A. Nettleton, Mark P. Purdue, Preetha Rajaraman, Eric B. Rimm, Lynda M. Rose, Nathaniel Rothman, Debra Silverman, Rachael Stolzenberg-Solomon, Amy Subar, Meredith Yeager, Daniel I. Chasman, Rob M. van Dam & Neil E. Caporaso. (2011) Genome-Wide Meta-Analysis Identifies Regions on 7p21 (AHR) and 15q24 (CYP1A2) As Determinants of Habitual Caffeine Consumption. PLoS Genetics 7:4, pages e1002033.
Crossref
Crossref
Rong Zhang, Jianguo Sun, Liping Ma, Xiaolan Wu, Guoyu Pan, Haiping Hao, Fang Zhou, Jiye A, Changhui Liu, Hua Ai, Lili Shang, Haiyan Gao, Ying Peng, Ping Wan, Hui Wu & Guangji Wang. (2011) Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. Toxicology and Applied Pharmacology 252:1, pages 18-27.
Crossref
Crossref
Patty M. M. Nooijen, Felix Carvalho & Robert J. Flanagan. (2011) Haematological toxicity of clozapine and some other drugs used in psychiatry. Human Psychopharmacology: Clinical and Experimental 26:2, pages 112-119.
Crossref
Crossref
Frank Musshoff, Ulrike M. Stamer & Burkhard Madea. (2010) Pharmacogenetics and forensic toxicology. Forensic Science International 203:1-3, pages 53-62.
Crossref
Crossref
Hye Young Ji, Sung Yeon Kim, Dong Kyun Kim, Ji Hyun Jeong & Hye Suk Lee. (2010) Effects of Eupatilin and Jaceosidin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes. Molecules 15:9, pages 6466-6475.
Crossref
Crossref
Natasa Djordjevic, Roza Ghotbi, Slobodan Jankovic & Eleni Aklillu. (2010) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism. European Journal of Clinical Pharmacology 66:7, pages 697-703.
Crossref
Crossref
Joanne Siok Liu Lim, Onkar Singh, Rathi Devi Ramasamy, Saminathan Ramasamy, Koilan Subramanian, Edmund J.D. Lee & Balram Chowbay. (2010) Pharmacogenetics of CYP1A2, Novel Polymorphisms and Haplotypes in Three Distinct Asian Populations. Drug Metabolism and Pharmacokinetics 25:6, pages 616-623.
Crossref
Crossref